Mr Brandon Paul Bodnariuk, PA-C | |
24 Frank Lloyd Wright Dr Lbby A, Ann Arbor, MI 48105-9484 | |
(734) 936-5738 | |
Not Available |
Full Name | Mr Brandon Paul Bodnariuk |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 24 Frank Lloyd Wright Dr Lbby A, Ann Arbor, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235715087 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 5601010426 (Michigan) | Secondary |
363A00000X | Physician Assistant | 5601010426 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Brandon Paul Bodnariuk, PA-C 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Mr Brandon Paul Bodnariuk, PA-C 24 Frank Lloyd Wright Dr Lbby A, Ann Arbor, MI 48105-9484 Ph: (734) 936-5738 |
News Archive
In the first ever clinical investigation involving genetic screening for Parkinson's disease, researchers are testing whether the presence of a specific genetic mutation identifies which patients are the best candidates for deep brain stimulation surgery, and whether neurologists should perform that procedure differently based on that genetic information.
Combination therapy with amrubicin and carboplatin is moderately effective in patients with advanced thymic carcinoma, a Japanese study finds, but invasive thymoma patients do not benefit from this regimen.
Scientists from the University of Sheffield are part of an international collaboration to develop a new class of drugs to treat a common genetic kidney disease which is a major cause of kidney failure.
Limerick BioPharma, Inc., a developer of innovative therapies that help cells pump unwanted or toxic substances away from vulnerable tissues, has announced positive results of a Phase 1a trial for its lead compound, LIM-0705, which has completed its first in man study.
Health information technology could improve health care quality, but it is not the cure-all solution to reducing U.S. health care costs, Congressional Budget Office Director Peter Orszag said at a forum on Friday, CQ HealthBeat reports. The forum was hosted by the Alliance for Health Reform and the Robert Wood Johnson Foundation.
› Verified 5 days ago